mRNA COVID-19 vaccine and oral lichen planus: A case report
- PMID: 35262981
- PMCID: PMC9115495
- DOI: 10.1111/odi.14184
mRNA COVID-19 vaccine and oral lichen planus: A case report
Keywords: COVID-19; Sars-Cov-2; m-RNA vaccine; oral lesions; oral lichen planus.
References
REFERENCES
-
- Alrashdan, M. S., Cirillo, N., & McCullough, M. (2016). Oral lichen planus: A literature review and update. Archives of Dermatological Research, 308, 539-551. https://doi.org/10.1007/s00403-016-1667-2
-
- Bian, L., Gao, Q., Gao, F., Wang, Q., He, Q., Wu, X., Mao, Q., Xu, M., & Liang, Z. (2021). Impact of the delta variant on vaccine efficacy and response strategies. Expert Review of Vaccines, 20(10), 1201-1209. https://doi.org/10.1080/14760584.2021.1976153
-
- Edwards, P. C., & Kelsch, R. (2002). Oral lichen planus: Clinical presentation and management. Journal (Canadian Dental Association), 68(8), 494-499.
-
- Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2021). Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 28(2):202-221. https://doi.org/10.1016/j.cmi.2021.10.005
-
- Ismail, S. B., Kumar, S. K. S., & Zain, R. B. (2007). Oral lichen planus and lichenoid reactions: Etiopathogenesis, diagnosis, management and malignant transformation. Journal of Oral Science, 49(2), 89-106. https://doi.org/10.2334/josnusd.49.89
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous